Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Lab Chip ; 19(17): 2905-2914, 2019 09 07.
Artículo en Inglés | MEDLINE | ID: mdl-31367713

RESUMEN

Microfabrication techniques have been applied to develop micron-scale devices for oral drug delivery with a high degree of control over size, shape and material composition. Recently, microcontainers have been introduced as a novel approach to obtain unidirectional release to avoid luminal drug loss, enhance drug permeation, protect drug payload from the harsh environment of the stomach, and explore the ability for targeted drug delivery. However, in order to eventually pave the way for real life applications of these microfabricated drug delivery systems, it is necessary to fabricate them in biodegradable materials approved for similar applications and with strategies that potentially allow for large scale production. In this study, we for the first time evaluate biodegradable microcontainers for oral drug delivery. Asymmetric poly-ε-caprolactone (PCL) microcontainers with a diameter of 300 µm and a volume of 2.7 nL are fabricated with a novel single-step fabrication process. The microcontainers are loaded with the model drug paracetamol and coated with an enteric pH-sensitive Eudragit® S100 coating to protect the drug until it reaches the desired location in the small intestine. In vitro dissolution studies are performed to assess the drug load and release profile of the PCL microcontainers. Finally, in vivo studies in rats showed a higher bioavailability compared to conventional dosage forms and confirm the potential of biodegradable microcontainers for oral drug delivery.


Asunto(s)
Acetaminofén/farmacocinética , Sistemas de Liberación de Medicamentos , Microtecnología , Poliésteres/química , Acetaminofén/administración & dosificación , Acetaminofén/química , Administración Oral , Animales , Liberación de Fármacos , Masculino , Microtecnología/instrumentación , Tamaño de la Partícula , Poliésteres/administración & dosificación , Ratas , Ratas Sprague-Dawley
2.
Can J Microbiol ; 52(6): 519-24, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16788719

RESUMEN

An intracellular glucose oxidase (GOD) was isolated from the mycelium extract of a locally isolated strain of Aspergillus niger NFCCP. The enzyme was partially purified to a yield of 28.43% and specific activity of 135 U mg(-1) through ammonium sulfate precipitation, anion-exchange chromatography, and gel filtration. The enzyme showed high specificity for D-glucose, with a K(m) value of 25 mmol L(-1). The enzyme exhibited optimum catalytic activity at pH 5.5. Optimum temperature for GOD-catalyzed D-glucose oxidation was 40 degrees C. The enzyme displayed a high thermostability having a half-life (t(1/2)) of 30 min, enthalpy of denaturation (H*) of 99.66 kJ mol(-1), and free energy of denaturation (G*) of 103.63 kJ mol(-1). These characteristics suggest that GOD from A. niger NFCCP can be used as an analytical reagent and in the design of biosensors for clinical, biochemical, and diagnostic assays.


Asunto(s)
Aspergillus niger/enzimología , Glucosa Oxidasa/aislamiento & purificación , Termodinámica , Aspergillus niger/aislamiento & purificación , Aspergillus niger/metabolismo , Estabilidad de Enzimas , Glucosa Oxidasa/química , Glucosa Oxidasa/metabolismo , Concentración de Iones de Hidrógeno , Cinética , Temperatura
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...